Eicosapentaenoic acid (EPA) reduces pulmonary endothelial dysfunction and inflammation due to changes in protein expression during exposure to particulate matter air pollution.

Sherratt, Samuel C R; Libby, Peter; Dawoud, Hazem; Bhatt, Deepak L; Malinski, Tadeusz; Mason, R Preston

Sherratt, Samuel C R; Libby, Peter; Dawoud, Hazem; Bhatt, Deepak L; Malinski, Tadeusz; Mason, R Preston.

Afiliação

Sherratt SCR; Department of Molecular, Cellular, and Biomedical Sciences, University of New Hampshire, Durham, NH, USA; Elucida Research LLC, Beverly, MA, USA.
Libby P; Department of Medicine, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Dawoud H; Nanomedical Research Laboratory, Ohio University, Athens, OH, USA.
Bhatt DL; Mount Sinai Heart, Icahn School of Medicine at Mount Sinai Health System, New York, NY, USA.
Malinski T; Nanomedical Research Laboratory, Ohio University, Athens, OH, USA. Electronic address: rpmason@elucidaresearch.com.
Mason RP; Elucida Research LLC, Beverly, MA, USA; Department of Medicine, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Biomed Pharmacother ; 162: 114629, 2023 Jun.

Article em En | MEDLINE | ID: mdl-37027984

Assuntos

Poluição do Ar; Doenças Cardiovasculares; Doenças Vasculares; Humanos; Material Particulado/efeitos adversos; Ácido Eicosapentaenoico; Proteômica; Inflamação/induzido quimicamente; Poluição do Ar/efeitos adversos

Palavras-chave

Air pollution; Eicosapentaenoic acid; Proteomics; Pulmonary endothelial function

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Vasculares / Doenças Cardiovasculares / Poluição do Ar Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google